L-lysine protects C2C12 myotubes and 3T3-L1 adipocytes against high glucose damages and stresses.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
22
07
2019
accepted:
14
11
2019
entrez:
20
12
2019
pubmed:
20
12
2019
medline:
31
3
2020
Statut:
epublish
Résumé
Hyperglycemia is a hallmark of diabetes, which is associated with protein glycation and misfolding, impaired cell metabolism and altered signaling pathways result in endoplasmic reticulum stress (ERS). We previously showed that L-lysine (Lys) inhibits the nonenzymatic glycation of proteins, and protects diabetic rats and type 2 diabetic patients against diabetic complications. Here, we studied some molecular aspects of the Lys protective role in high glucose (HG)-induced toxicity in C2C12 myotubes and 3T3-L1 adipocytes. C2C12 and 3T3-L1 cell lines were differentiated into myotubes and adipocytes, respectively. Then, they were incubated with normal or high glucose (HG) concentrations in the absence/presence of Lys (1 mM). To investigate the role of HG and/or Lys on cell apoptosis, oxidative status, unfolded protein response (UPR) and autophagy, we used the MTT assay and flow cytometry, spectrophotometry and fluorometry, RT-PCR and Western blotting, respectively. In both cell lines, HG significantly reduced cell viability and induced apoptosis, accompanying with the significant increase in reactive oxygen species (ROS) and nitric oxide (NO). Furthermore, the spliced form of X-box binding protein 1 (XBP1), at both mRNA and protein levels, the phosphorylated eukaryotic translation initiation factor 2α (p-eIf2α), and the Light chain 3 (LC3)II/LC3I ratio was also significantly increased. Lys alone had no significant effects on most of these parameters; but, treatment with HG plus Lys returned them all to, or close to, the normal values. The results indicated the protective role of Lys against glucotoxicity induced by HG in C2C12 myotubes and 3T3-L1 adipocytes.
Identifiants
pubmed: 31856203
doi: 10.1371/journal.pone.0225912
pii: PONE-D-19-20629
pmc: PMC6922410
doi:
Substances chimiques
Reactive Oxygen Species
0
Nitric Oxide
31C4KY9ESH
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0225912Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Pharmacology. 2005 Feb;73(2):106-12
pubmed: 15528954
Exp Clin Endocrinol. 1988 May;91(2):155-60
pubmed: 3409968
Thromb Res. 2012 Sep;130(3):e13-9
pubmed: 22575419
Cell Physiol Biochem. 2014;33(1):107-16
pubmed: 24481000
Curr Opin Cell Biol. 2006 Aug;18(4):444-52
pubmed: 16781856
Cell Death Differ. 2006 Mar;13(3):374-84
pubmed: 16397578
Autophagy. 2009 Jul;5(5):585-9
pubmed: 19411822
Curr Vasc Pharmacol. 2003 Oct;1(3):335-46
pubmed: 15320480
Am J Physiol Cell Physiol. 2010 Apr;298(4):C776-85
pubmed: 20089931
J Immunol Methods. 1984 May 25;70(2):257-68
pubmed: 6609997
Indian J Clin Biochem. 2009 Oct;24(4):324-42
pubmed: 23105858
Annu Rev Genet. 2009;43:67-93
pubmed: 19653858
Expert Opin Investig Drugs. 2002 Sep;11(9):1205-23
pubmed: 12225243
J Inherit Metab Dis. 2012 Nov;35(6):1011-9
pubmed: 22403019
Annu Rev Pathol. 2008;3:399-425
pubmed: 18039139
Biosci Biotechnol Biochem. 2016 Nov;80(11):2168-2175
pubmed: 27427787
Circulation. 2006 Apr 18;113(15):1888-904
pubmed: 16618833
Nat Rev Mol Cell Biol. 2012 Jan 18;13(2):89-102
pubmed: 22251901
PLoS One. 2013 Oct 02;8(10):e74130
pubmed: 24098333
Mol Cell Biochem. 2014 Jun;391(1-2):37-46
pubmed: 24532005
Cancer Res. 2012 Mar 15;72(6):1321-31
pubmed: 22422988
Pediatr Res. 2002 Dec;52(6):832-6
pubmed: 12438657
Circulation. 1998 Jan 6-13;97(1):108-12
pubmed: 9443438
Cell Stress Chaperones. 1996 Jun;1(2):109-15
pubmed: 9222596
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Life Sci. 2019 Jan 1;216:246-258
pubmed: 30471281
Nature. 1977 Dec 22-29;270(5639):725-7
pubmed: 563524
BMC Complement Altern Med. 2015 Jun 23;15:193
pubmed: 26100532
Biochem Biophys Res Commun. 2003 Sep 12;309(1):196-200
pubmed: 12943682
Am J Physiol Heart Circ Physiol. 2009 Jan;296(1):H106-18
pubmed: 18978194
Diabetes Obes Metab. 2010 Oct;12 Suppl 2:108-15
pubmed: 21029307
J Biol Chem. 2008 Dec 5;283(49):34260-72
pubmed: 18854310
Acta Med Iran. 2016 Jan;54(1):24-31
pubmed: 26853287
PLoS One. 2014 Apr 09;9(4):e94545
pubmed: 24718591
Nature. 2001 Dec 13;414(6865):813-20
pubmed: 11742414
Int J Toxicol. 2004 Mar-Apr;23(2):113-8
pubmed: 15204731
Br J Pharmacol. 1997 Oct;122(4):742-8
pubmed: 9375972
Protein J. 2011 Oct;30(7):480-9
pubmed: 21882049
Diabetes. 1999 Apr;48(4):927-32
pubmed: 10102716
Diabetes Care. 2002 Jun;25(6):1055-9
pubmed: 12032114
Int J Biol Macromol. 2019 Jul 1;132:1200-1207
pubmed: 30965074
J Biomol Struct Dyn. 2011 Feb;28(4):575-86
pubmed: 21142225
Eur J Clin Nutr. 2016 Mar;70(3):306-12
pubmed: 26395436
Diabet Med. 2009 Dec;26(12):1185-92
pubmed: 20002468
Methods Enzymol. 2014;542:243-62
pubmed: 24862270
J Diabetes Res. 2014;2014:795171
pubmed: 24812634
Eur J Haematol. 1997 May;58(5):307-13
pubmed: 9222285
Reproduction. 2011 May;141(5):607-15
pubmed: 21367963
Histochemistry. 1992 Jul;97(6):493-7
pubmed: 1385366
Endocrinology. 2009 Jan;150(1):63-74
pubmed: 18772236
J Chem Neuroanat. 2004 Sep;28(1-2):101-5
pubmed: 15363495
Free Radic Biol Med. 2003 Nov 15;35(10):1240-51
pubmed: 14607523
Curr Med Chem. 2005;12(3):267-75
pubmed: 15723618
Int J Cell Biol. 2010;2010:930509
pubmed: 20145727
Cell. 2015 Oct 22;163(3):620-8
pubmed: 26456111
Diabetes Metab Res Rev. 2008 Jan-Feb;24(1):64-73
pubmed: 17879961
Nat Rev Mol Cell Biol. 2011 Dec 14;13(1):7-12
pubmed: 22166994
Biochim Biophys Acta. 2014 Feb;1840(2):730-8
pubmed: 23665586
Cell Death Differ. 2011 Oct;18(10):1617-27
pubmed: 21436843